RxDoctor Payments Data

John Schleifer, MD

Clinical Cardiac Electrophysiology · Omaha, NENPI 1356585590

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by Philips North America LLC at 46.4% of the total. Reporting peaked in 2022 at $1,666 and has fallen 76.3% since, to $396 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NE, where the typical reported total is $23,571.

$5,267in general payments, 2019–2025

Across 55 payments — averaging $95.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$2K
  • Boston Scientific$1K
  • Medtronic$503
  • Biosense Webster, Inc.$346
  • Abbott$326
  • Atricure, Inc.$130
  • plus $38 from 1 others
$23,203in research payments, 2019–2025

Across 14 payments — averaging $1657.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$23K

What the payments were for

  • Travel & lodging$2,41046%
  • Food & beverage$2,85754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,267 in reported general payments places this provider in the 25th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.

See all clinical cardiac electrophysiology providers in Nebraska

Medicare billing

Part B allowed, 2024
$145,465
Medicare patients
1,791
Services billed
3,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban256$288,423
XareltoRivaroxaban65$64,259
EntrestoSacubitril/Valsartan15$15,436
Dabigatran EtexilateDabigatran Etexilate Mesylate16$4,351
Flecainide Acetate68$2,912
Metoprolol Succinate141$2,469
Dofetilide22$2,002
Amiodarone Hcl114$1,679
Mexiletine Hcl21$1,383
SotalolSotalol Hcl21$507
Propafenone Hcl11$475
Potassium Chloride27$456
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$425
Metoprolol Tartrate57$290
Warfarin Sodium27$244

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →